Close this search box.
Close this search box.

New Follow Up Study Finds Increased Risk of VTE With Vaginal Ring

By Rheingold Giuffra Ruffo & Plotkin LLP

A new follow up study by Øjvind Lidegaard found that compared to combined oral contraceptives containing levonorgestrel users of vaginal ring contraceptives (such as NuvaRing) were 1.9 times more likely to suffer venous thrombosis. The VTE risk of vaginal ring users was 6.5 times higher than women not taking hormonal birth control.

The study also found an increase risk in transdermal patch birthcontrol as well, with women with 2.3 times more likely to have a VTE compared to users of combined oral contraceptives containing levonorgestrel and 7.9 times more likely than non users of hormonal contraceptives.

A copy of the article, which was published in the British Medical Journal in May 2012 can her found here.

Our firm represents hundreds of women who have suffered from injuries stemming from NuvaRing and other birth controls. If you have been injured after taking birth control please contact the attorneys at Rheingold, Giuffra, Ruffo & Plotkin LLP for a free consultation with an experienced drug injury attorney.

Related Posts

Paragard Bellwether Trial Update

The Paragard Multidistrict Litigation is moving forward after US District Court Judge issued the latest scheduling order concerning deadlines for discovery, including disclosure of experts

View Article